Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001947798 | SCV002190732 | uncertain significance | not provided | 2022-02-19 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. This variant has not been reported in the literature in individuals affected with COL4A1-related conditions. This variant is present in population databases (rs771634502, gnomAD 0.004%). This sequence change falls in intron 27 of the COL4A1 gene. It does not directly change the encoded amino acid sequence of the COL4A1 protein. It affects a nucleotide within the consensus splice site. |
Ce |
RCV001947798 | SCV002585455 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | COL4A1: BP4 |
Fulgent Genetics, |
RCV005006226 | SCV005632416 | likely benign | Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome; Brain small vessel disease 1 with or without ocular anomalies; Hemorrhage, intracerebral, susceptibility to; Retinal arterial tortuosity; Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | 2024-06-13 | criteria provided, single submitter | clinical testing |